Cryoablation of Intercostal Nerves for Post-Operative Pain Management in Opioid-Tolerant Patients

• Status: Not yet recruiting
• Trial end date: 2024-09-15
• Target enrollment: 0
• Participant gender: All

Summary

The main objective is to evaluate the efficacy of cryoSPHERE ablation of intercostal nerves in improving post-operative pain after undergoing robotic assisted thoracoscopic anatomic lung resection in opioid-tolerant patients to address whether cryoSPHERE can help reduce the need for opioid drugs for postoperative pain management in the opioid-tolerant patient population.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Methodist Hospital Research Institute
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Male and female patients 18-90 years of age

• Diagnosis requiring robotic-assisted thoracoscopic surgery

• 3. Daily opioid use for at least 30 days consecutively at any point during the last 12 months prior to surgery.

• Agreement and consent to comply with all aspects of the study protocol and data collection, including follow-up contact.

Exclusion Criteria:

• Previous major surgery at the operative site (thoracotomy)

• Allergy to aluminum

• Allergy to plastics

• Allergy to bupivacaine

• Shingles disease

• Demyelinating illnesses

• Involvement with other interventional studies